Related Experiment Videos
Neuronal changes in the nigrostriatal pathway of 1-methyl-4-phenylpyridine-treated mice
M L Boatell1, N Mahy, A Cardozo
1Neurological Tissue Bank, University of Barcelona, Spain.
Abstract:
Thirty young-adult mice were treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 30 mg/kg/day for 2 days and sacrificed 24 hours later in order to determine striatal catecholamines and to study morphological changes in the nigrostriatal pathway. Immunohistological techniques were also used with polyclonal antibodies for glial fibrillary acidic protein (GFAP) and tyrosine hydroxylase (TH), and monoclonal antibodies for two subunits of neurofilaments. Silver impregnation demonstrated conspicuous neuronal changes affecting cellular processes from substantia nigra in all treated mice. Terminal and axonal degeneration were also observed in striata. These changes were associated with a moderate to marked gliosis. The TH immunoreactivity was normal in cell bodies of substantia nigra but was decreased in striata from MPTP-treated mice. These data indicate that in mice the deterioration of dendritic and axonal neuropil may constitute a significant causal factor of MPTP neurotoxicity.
Insights
MPTP exposure in mice caused neuronal damage in the substantia nigra and striata, leading to decreased tyrosine hydroxylase. This neurotoxicity is linked to the deterioration of neuronal processes.
Area of Science:
- Neuroscience
- Toxicology
- Neurobiology
Background:
- 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin known to induce Parkinsonism-like symptoms.
- The nigrostriatal pathway, crucial for motor control, is particularly vulnerable to MPTP toxicity.
Purpose of the Study:
- To investigate the morphological and neurochemical alterations in the nigrostriatal pathway of mice following MPTP administration.
- To elucidate the role of neuronal and axonal degeneration in MPTP-induced neurotoxicity.
Main Methods:
- Young adult mice were administered MPTP (30 mg/kg/day for 2 days) and sacrificed 24 hours later.
- Immunohistochemistry was employed using antibodies for glial fibrillary acidic protein (GFAP) and tyrosine hydroxylase (TH).
- Silver impregnation techniques were used to visualize neuronal changes and neurofilament subunits.
Main Results:
- MPTP treatment induced significant neuronal changes in the substantia nigra and degeneration of terminals and axons in the striata.
- A moderate to marked gliosis was observed in the affected brain regions.
- While tyrosine hydroxylase (TH) immunoreactivity remained normal in substantia nigra cell bodies, it was decreased in the striata.
Conclusions:
- Deterioration of dendritic and axonal neuropil is a significant factor in MPTP neurotoxicity in mice.
- MPTP-induced damage to the nigrostriatal pathway affects both neuronal structure and neurotransmitter levels.
- These findings contribute to understanding the mechanisms underlying MPTP-induced neurodegeneration.